Literature DB >> 24270302

Mica dust and pneumoconiosis: example of a pure occupational exposure in a muscovite milling unit.

Sébastien Hulo1, Nathalie Cherot-kornobis, Jean-Louis Edme, Virginie de Broucker, Guillaume Falgayrac, Guillaume Penel, Karinne Legrand-Cattan, Jacques Remy, Annie Sobaszek.   

Abstract

OBJECTIVE: We present pulmonary disorders of four employees who were exposed to high concentration of pure mica dust in a muscovite milling unit.
METHOD: All cases underwent traditional examinations with a dual-energy chest computed tomographic scan. An analysis of exhaled breath condensate by Raman microspectrometry and of mineralogical content of a lung biopsy was performed for one case.
RESULTS: All cases showed bilateral micronodular ground glass opacities and mediastinal and hilar hyperdense lymph nodes consistent with the nodal sequestration of mineral particles. Histological analysis showed giant cell granulomas without typical silicotic nodule with high concentration of birefringent particles consistent with mica. Mica particles found in the exhaled breath condensate were identical to particles in ambient air at the company.
CONCLUSION: Occupational exposure to mica dust is responsible for diffuse infiltrative lung disease by overload processes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24270302     DOI: 10.1097/JOM.0000000000000004

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Demonstrating the protective effect of a 70-year-old occupational exposure limit against pneumoconiosis caused by mica.

Authors:  Kristian W Fried; Paul C DeLeo
Journal:  Toxicol Ind Health       Date:  2022-03-01       Impact factor: 2.273

2.  The importance of mineralogical composition for the cytotoxic and pro-inflammatory effects of mineral dust.

Authors:  Vegard Sæter Grytting; Magne Refsnes; Marit Låg; Eyolf Erichsen; Torkil Sørlie Røhr; Brynhild Snilsberg; Richard Aubrey White; Johan Øvrevik
Journal:  Part Fibre Toxicol       Date:  2022-07-06       Impact factor: 9.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.